
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.100 | 1.100 | 0.000 |
Shares | 98.900 | 98.900 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 34.338 | 35.834 |
Price to Book | 4.847 | 4.936 |
Price to Sales | 5.090 | 5.149 |
Price to Cash Flow | 13.616 | 24.369 |
Dividend Yield | 0.684 | 0.628 |
5 Years Earnings Growth | 17.108 | 13.691 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.060 | 96.429 |
Basic Materials | 0.940 | 4.570 |
Number of long holdings: 42
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 10.08 | 1,608.40 | +1.35% | |
Cipla | INE059A01026 | 5.48 | 1,504.80 | +1.28% | |
Ajanta Pharma Ltd | INE031B01049 | 4.92 | 2,649.30 | +1.68% | |
Procter & Gamble Health | INE199A01012 | 4.30 | 6,338.50 | -0.07% | |
Dr Reddy’s Laboratories | INE089A01031 | 4.20 | 1,219.50 | +0.67% | |
Glenmark Pharma | INE935A01035 | 3.99 | 2,049.30 | +1.47% | |
Lupin | INE326A01037 | 3.53 | 1,944.80 | +1.40% | |
Apollo Hospitals | INE437A01024 | 3.49 | 7,259.00 | +2.46% | |
Divi's Labs | INE361B01024 | 3.47 | 5,992.00 | +1.31% | |
Fortis Healthcare | INE061F01013 | 3.36 | 920.65 | +2.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UTI Equity Fund Growth Option D | 263.25B | 2.21 | 11.81 | 12.58 | ||
UTI Equity Fund Income Option D | 263.25B | 2.21 | 11.78 | 12.46 | ||
UTI Equity Fund Growth | 263.25B | 1.84 | 11.00 | 11.88 | ||
UTI Equity Fund Dividend Payout | 263.25B | 1.84 | 10.97 | 11.75 | ||
UTI Mastershare Unit Div Payout | 127.2B | 4.01 | 13.05 | 9.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review